Bosch Service Solutions is an international provider of technology-based services, offering integrated service solutions in the automotive, logistics, healthcare, and communications technology industries.

Bosch Service Solutions

Avanti Research specializes in the development and manufacturing of lipids and lipid-based formulations, self-described as a leader in the pharmaceutical and diagnostic industries.

Avanti Research

Bosch Rexroth is a company that provides technology and solutions for industrial applications, focusing on automation, motion control, and mobile hydraulics.

Bosch Rexroth

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Metric
Company Name	Bosch Service Solutions	Avanti Research	Bosch Rexroth	Fresenius Medical Care AG & Co. KGaA
Symbol				FME
MSH ID	COM:BOSCHSERVICESOLUTIONS	COM:AVANTIRESEARCH	COM:BOSCHREXROTH	COM:FRESENIUSMEDICALCARE
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Commercial & Professional Services	Healthcare & Health Services	Capital Goods & Industrials	Healthcare
Industry	Technology Services	Biotechnology	Industrial Technology and Automation	Medical - Care Facilities
Country	DE	US	DE	DE
Stage
Employee Count			12.11K	117.13K
Website	boschservicesolutions.com	avantiresearch.com	boschrexroth.com	freseniusmedicalcare.com
LinkedIn			bosch-rexroth	fresenius-medical-care-italia-spa
Founders

Metric
Market Cap				11.22B
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue				20.55B
Revenue (LTM)
Revenue (NTM)
Gross Profit				5.20B
EBITDA				3.63B
Operating Income				1.58B
Net Income				527.06M
EPS				1.80
Diluted EPS				1.80
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.25
Operating Profit Margin				0.08
EBITDA Margin				0.18
Net Profit Margin				0.03
Return on Equity				0.04
Return on Assets				0.02
Return on Capital Employed				0.06

COM:BOSCHSERVICESOLUTIONS

Bosch Service Solutions

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				19.14
P/B Ratio				0.75
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				0.63
EV Multiple				0.95

Metric
Days Sales Outstanding				69.66
Days Payables Outstanding				21.21
Days Inventory Outstanding				56.09
Operating Cycle				132.45
Cash Conversion Cycle				112.72
Asset Turnover				0.62

Metric
Operating Cash Flow				2.78B
Free Cash Flow				2.05B
Cash Flow to Debt				0.34
Operating Cash Flow/Sales				0.16
Free Cash Flow Yield				0.16

Metric
Cash & Equivalents				1.48B
Accounts Receivable				-160.38M
Inventory				2.30B
Goodwill				15.47B
Debt to Capitalization				0.47
Debt to Assets				0.36
Current Ratio				1.37
Quick Ratio				1.14

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				-0.02
R&D to Revenue				0.01
SG&A to Revenue